|
|
|
| ↓ 公司简介
|
北京莱瑞森医药科技有限公司
posted by
lunarsunsi
|
|
|
|
| 主要产品: |
化学原料药,中间体 |
| 商业类型: |
制造商 |
| 成立年份: |
2000 |
| 传真号码: |
-- |
|
|
| 地址: |
Building No. 18, Yard No. 11, Xisha Industrial Zone, Changping District |
| 主要市场: |
南美洲 亚洲 |
| 涉及行业: |
化工> 医药化学品 化工> 医药中间体 |
|
|
|
|
|
|
|
| 共
39 条供应信息。 |
|
D-2-Chloropropionyl chloride [
$ 价格待议] |
| 发布时间: 2010-02-08 10:54
|
|
D-2-Chloropropionyl chloride,
If you are interested in the following product, please feel free to contact us:
E-mail: lunarsun-si@live.cn
|
|
(R)-(+)-2-Chloropropionic Acid [
$ 价格待议] |
| 发布时间: 2010-02-08 10:52
|
|
(R)-(+)-2-Chloropropionic Acid, CAS No.:7474-05-7
If you are interested in the following product, please feel free..
|
|
tert-butyl acetate [
$ 价格待议] |
| 发布时间: 2010-02-08 10:50
|
|
tert-butyl acetate, CAS No.:540-88-5
If you are interested in the following product, please feel free to contact..
|
|
tert-Butyl chloroacetate [
$ 价格待议] |
| 发布时间: 2010-02-08 10:36
|
|
tert-Butyl chloroacetate, CAS No.:107-59-5
If you are interested in the following product, please feel free to..
|
|
tert-Butyl bromoacetate [
$ 价格待议] |
| 发布时间: 2010-02-08 10:34
|
|
tert-Butyl bromoacetate, CAS No.:5292-43-3
If you are interested in the following product, please feel free to..
|
|
Voriconazole, [
$ 价格待议] |
| 发布时间: 2010-02-08 10:31
|
|
Voriconazole,
We can also provide its intermediates described as..
|
|
Telmisartan, [
$ 价格待议] |
| 发布时间: 2010-02-08 10:29
|
|
Telmisartan,
We can also provide its intermediates described as follows:
4’-bromomethylbipheneyl-2-carboxylic..
|
|
Ritonavir, [
$ 价格待议] |
| 发布时间: 2010-02-08 10:28
|
|
Ritonavir,
We can also provide its intermediates described as follows:
(2S,3S,5S)-2-Amino-3-hydroxy- 5-(tert-butyloxy..
|
|
Pemetrexed [
$ 价格待议] |
| 发布时间: 2010-02-08 10:26
|
|
Pemetrexed
We can also provide its intermediates described as..
|
|
Olopatadine [
$ 价格待议] |
| 发布时间: 2010-02-08 10:24
|
|
Olopatadine
We can also provide its intermediates described as..
|
|
Moxifloxacin [
$ 价格待议] |
| 发布时间: 2010-02-08 11:13
|
|
Moxifloxacin
We can also provide its intermediates described as..
|
|
Lafutidine [
$ 价格待议] |
| 发布时间: 2010-02-08 11:12
|
|
Lafutidine
We can also provide its intermediates described as..
|
|
Imipenem [
$ 价格待议] |
| 发布时间: 2010-02-08 11:12
|
|
Imipenem
We can also provide its intermediates described as..
|
|
Imatinib [
$ 价格待议] |
| 发布时间: 2010-02-08 11:12
|
|
Imatinib
We can also provide its intermediates described as follows:
N-(5-amino-2-MethylPhenyl) -4- (3-Pyridyl)..
|
|
Gemcitabine [
$ 价格待议] |
| 发布时间: 2010-02-08 11:11
|
|
Gemcitabine
We can also provide its intermediates described as..
|
|
Gabapentin [
$ 价格待议] |
| 发布时间: 2010-02-08 11:10
|
|
Gabapentin
We can also provide its intermediates described as follows:
1,1-Cyclohexanediacetic acid ..
|
|
Faropenem [
$ 价格待议] |
| 发布时间: 2010-02-08 11:10
|
|
Faropenem
We can also provide its intermediates described as..
|
|
Famciclovir [
$ 价格待议] |
| 发布时间: 2010-02-08 11:10
|
|
Famciclovir
We can also provide its intermediate described as..
|
|
Ertapenem [
$ 价格待议] |
| 发布时间: 2010-02-08 11:10
|
|
Ertapenem
We can also provide its intermediates described as..
|
|
Erlotinib [
$ 价格待议] |
| 发布时间: 2010-02-08 11:09
|
|
Erlotinib
We can also provide its intermediates described as follows:
ethyl..
|
|
Dalasetron [
$ 价格待议] |
| 发布时间: 2010-02-08 11:09
|
|
Dalasetron
We can also provide its intermediate described as follow:
3-Cyclopentene-1-carboxylic..
|
|
Darifenacin [
$ 价格待议] |
| 发布时间: 2010-02-08 11:08
|
|
Darifenacin
We can also provide its intermediates described as..
|
|
Citalopram [
$ 价格待议] |
| 发布时间: 2010-02-08 11:08
|
|
Citalopram
We can also provide its intermediates described as..
|
|
Capecitabine [
$ 价格待议] |
| 发布时间: 2010-02-08 11:08
|
|
Capecitabine
We can also provide its intermediates described as follows:
5–deoxy-1,2,3-ti..
|
|
Aztreonam [
$ 价格待议] |
| 发布时间: 2010-02-08 11:07
|
|
Aztreonam
We can also provide its intermediate described as..
|
|
Amisulpride [
$ 价格待议] |
| 发布时间: 2010-02-08 11:06
|
|
Amisulpride
We can also provide its intermediates described as follows:
Methyl..
|
|
Adefovir [
$ 价格待议] |
| 发布时间: 2010-02-08 11:06
|
|
Adefovir
We can also provide its intermediate described as follow:
[[2-(6-amino-9H-purin-9-yl) ethoxy] methyl]..
|
|
Vecuronium Bromide [
$ 价格待议] |
| 发布时间: 2010-02-08 11:06
|
|
Vecuronium Bromide, CAS No: 50700-72-6
If you are interested in the following product, please feel free to contact..
|
|
Methylcobalamin [
$ 价格待议] |
| 发布时间: 2010-02-08 11:05
|
|
Methylcobalamin, CAS No: 13422-55-4
If you are interested in the following product, please feel free to contact..
|
|
Tolterodine tartrate [
$ 价格待议] |
| 发布时间: 2010-02-08 11:05
|
|
Tolterodine tartrate, CAS No.: 124937-52-6
If you are interested in the following product, please feel free to..
|
|
N(2)-L-alanyl-L-glutamine [
$ 价格待议] |
| 发布时间: 2010-02-08 11:05
|
|
N(2)-L-alanyl-L-glutamine, CAS No.: 39537-23-0
If you are interested in the following product, please feel free..
|
|
Orlistat [
$ 价格待议] |
| 发布时间: 2010-02-08 11:04
|
|
Orlistat, CAS No: 96829-58-2
If you are interested in the following product, please feel free to contact..
|
|
Quetiapine Fumarate [
$ 价格待议] |
| 发布时间: 2010-02-08 11:04
|
|
Quetiapine Fumarate, CAS No:111974-72-2
If you are interested in the following product, please feel..
|
|
Voglibose [
$ 价格待议] |
| 发布时间: 2010-02-08 11:03
|
|
Voglibose, CAS No. 83480-29-9
If you are interested in the following product, please feel free to..
|
|
Temozolomide [
$ 价格待议] |
| 发布时间: 2010-02-08 11:03
|
|
Temozolomide, CAS No.: 85622-93-1
If you are interested in the following product, please feel free to contact..
|
|
Fludarabine Phosphate [
$ 价格待议] |
| 发布时间: 2010-02-08 11:03
|
|
Fludarabine Phosphate , CAS No.: 75607-67-9
If you are interested in the following product, please feel free to..
|
|
Dacarbazine [
$ 价格待议] |
| 发布时间: 2010-02-08 11:02
|
|
Dacarbazine, CAS No.: 4342-03-4
If you are interested in the following product, please feel free to contact us:
E-mail: lunarsun-si@live.cn
|
|
Valacyclovir HCL [
$ 价格待议] |
| 发布时间: 2010-02-08 11:02
|
|
Valacyclovir HCL, CAS No.: 124832-27-5
If you are interested in the following product, please feel free to..
|
|
|
|
|
|
|
|
|